191 related articles for article (PubMed ID: 17926516)
1. [Nanoparticles (part 2)--advantages and health risk].
Swidwińska-Gajewska AM
Med Pr; 2007; 58(3):253-63. PubMed ID: 17926516
[TBL] [Abstract][Full Text] [Related]
2. [Nanotechnology--possibilities and hazards].
Snopczyński T; Góralczyk K; Czaja K; Struciński P; Hernik A; Korcz W; Ludwicki JK
Rocz Panstw Zakl Hig; 2009; 60(2):101-11. PubMed ID: 19803438
[TBL] [Abstract][Full Text] [Related]
3. [Occupational exposure to nanoparticles. Assessment of workplace exposure].
Bujak-Pietrek S
Med Pr; 2010; 61(2):183-9. PubMed ID: 20509555
[TBL] [Abstract][Full Text] [Related]
4. [Nanoparticles (part 1)--the product of modern technology and new hazards in the work environment].
Swidwińska-Gajewska AM
Med Pr; 2007; 58(3):243-51. PubMed ID: 17926515
[TBL] [Abstract][Full Text] [Related]
5. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.
Tsuji JS; Maynard AD; Howard PC; James JT; Lam CW; Warheit DB; Santamaria AB
Toxicol Sci; 2006 Jan; 89(1):42-50. PubMed ID: 16177233
[TBL] [Abstract][Full Text] [Related]
6. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
Oberdörster G
J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
[TBL] [Abstract][Full Text] [Related]
7. Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks.
Warheit DB; Sayes CM; Reed KL; Swain KA
Pharmacol Ther; 2008 Oct; 120(1):35-42. PubMed ID: 18703086
[TBL] [Abstract][Full Text] [Related]
8. Review of health safety aspects of nanotechnologies in food production.
Bouwmeester H; Dekkers S; Noordam MY; Hagens WI; Bulder AS; de Heer C; ten Voorde SE; Wijnhoven SW; Marvin HJ; Sips AJ
Regul Toxicol Pharmacol; 2009 Feb; 53(1):52-62. PubMed ID: 19027049
[TBL] [Abstract][Full Text] [Related]
9. Application of a pilot control banding tool for risk level assessment and control of nanoparticle exposures.
Paik SY; Zalk DM; Swuste P
Ann Occup Hyg; 2008 Aug; 52(6):419-28. PubMed ID: 18632731
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles: their potential toxicity, waste and environmental management.
Bystrzejewska-Piotrowska G; Golimowski J; Urban PL
Waste Manag; 2009 Sep; 29(9):2587-95. PubMed ID: 19427190
[TBL] [Abstract][Full Text] [Related]
11. Do nanoparticles present ecotoxicological risks for the health of the aquatic environment?
Moore MN
Environ Int; 2006 Dec; 32(8):967-76. PubMed ID: 16859745
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-induced pulmonary toxicity.
Li JJ; Muralikrishnan S; Ng CT; Yung LY; Bay BH
Exp Biol Med (Maywood); 2010 Sep; 235(9):1025-33. PubMed ID: 20719818
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus?
Shvedova AA; Kisin ER; Porter D; Schulte P; Kagan VE; Fadeel B; Castranova V
Pharmacol Ther; 2009 Feb; 121(2):192-204. PubMed ID: 19103221
[TBL] [Abstract][Full Text] [Related]
14. [Nanotubes and fullerenes: an overview of the possible environmental and biological impact of bio-nanotechnologies].
Bottini M; Magrini A; Bottini N; Bergamaschi A
Med Lav; 2003; 94(6):497-505. PubMed ID: 14768242
[TBL] [Abstract][Full Text] [Related]
15. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species.
Carlson C; Hussain SM; Schrand AM; Braydich-Stolle LK; Hess KL; Jones RL; Schlager JJ
J Phys Chem B; 2008 Oct; 112(43):13608-19. PubMed ID: 18831567
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology safety concerns revisited.
Stern ST; McNeil SE
Toxicol Sci; 2008 Jan; 101(1):4-21. PubMed ID: 17602205
[TBL] [Abstract][Full Text] [Related]
17. [Nanotechnology & nanoparticles and their advances of investigation and application in the fields of biomedicine].
Xu B; Xia M; Deng Y; Hu C; Xu Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Apr; 21(2):333-6. PubMed ID: 15143571
[TBL] [Abstract][Full Text] [Related]
18. Advancing risk assessment of engineered nanomaterials: application of computational approaches.
Gajewicz A; Rasulev B; Dinadayalane TC; Urbaszek P; Puzyn T; Leszczynska D; Leszczynski J
Adv Drug Deliv Rev; 2012 Dec; 64(15):1663-93. PubMed ID: 22664229
[TBL] [Abstract][Full Text] [Related]
19. Nanotoxicology and in vitro studies: the need of the hour.
Arora S; Rajwade JM; Paknikar KM
Toxicol Appl Pharmacol; 2012 Jan; 258(2):151-65. PubMed ID: 22178382
[TBL] [Abstract][Full Text] [Related]
20. [Risk of nanoparticles?].
Aust W; Daum N; Bloching M; Armbrüster V; Jung E; Sprau C; Müller M; Boehm A; Mozet C; Wichmann G; Dietz A
Laryngorhinootologie; 2009 Mar; 88(3):162-6. PubMed ID: 19247893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
